Allergic Rhinitis Management

First-Line Treatment Selection

The American Academy of Otolaryngology-Head and Neck Surgery recommends intranasal corticosteroids as the first-line therapy for most patients with allergic rhinitis, as they are the most effective monotherapy for controlling all nasal symptoms 1, 2
For immediate symptom relief, the Journal of Allergy and Clinical Immunology suggests using intranasal antihistamines, which work within hours and are equal to or superior to oral antihistamines for seasonal allergic rhinitis 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends adding intranasal antihistamine to intranasal corticosteroid for inadequate response to corticosteroids alone, as this is the most effective combination 1, 2
For severe nasal congestion, the American Academy of Otolaryngology-Head and Neck Surgery suggests adding topical oxymetazoline to intranasal corticosteroid for maximum 3-5 days only to avoid rebound congestion 2

The Journal of Allergy and Clinical Immunology states that avoidance is the most effective management strategy and must be implemented alongside pharmacotherapy, with measures such as humidity control, dust mite covers, HEPA vacuuming, and acaricides for dust mites, and complete avoidance of animal allergens 3, 4

The Journal of Allergy and Clinical Immunology notes that patients with allergic rhinitis have increased risk for developing asthma, and treatment of allergic rhinitis improves asthma control, with intranasal corticosteroids showing a trend toward beneficial effect on asthma symptoms 3, 5

The Journal of Allergy and Clinical Immunology suggests considering allergen immunotherapy for patients with inadequate response to usual treatments, as it is the only treatment that can modify disease natural history, with benefits sustained for years after discontinuation 3, 4, 6

The Journal of Allergy and Clinical Immunology recommends periodic assessment of quality of life, including evaluation of time lost from work or activities, sleep quality, smell and taste function, and fatigue level and general well-being 4, 7, 6

Intranasal corticosteroids (e.g., fluticasone, mometasone, budesonide, triamcinolone) are the most effective single medication for allergic rhinitis and reduce ocular tearing by suppressing systemic allergic inflammation. 8
Topical nasal decongestants (e.g., oxymetazoline) used for more than 3–5 days cause rebound congestion (rhinitis medicamentosa) that can worsen eye‑watering and overall disease control. 8
Oral second‑generation antihistamines provide less comprehensive symptom relief than intranasal corticosteroids for allergic rhinitis‑related eye symptoms. [9][10]

Remaining in air‑conditioned environments with windows and doors closed during peak pollen periods reduces ocular and nasal allergic symptoms. [8][9]

Patients whose symptoms persist for 2–4 weeks and interfere with occupational performance meet criteria for specialist referral. [8][9]10

Regular assessment of work productivity, sleep quality, and overall well‑being serves as a key indicator of treatment success. [9][11]
Development of sinusitis or new asthma‑type symptoms warrants prompt specialist evaluation. [9][10]

Early, aggressive therapy with intranasal corticosteroids improves functional outcomes and prevents disease progression more effectively than delayed treatment. [8][9]

Excessive tearing in allergic rhinitis reflects a unified airway inflammatory response; intranasal corticosteroids target this systemic inflammation, thereby alleviating eye symptoms despite nasal administration. 11